What is PulseOn?
PulseOn is a Finland-based high-tech firm specializing in advanced arrhythmia detection devices and sophisticated analysis software tailored for professional medical applications. The company's core innovation lies in its wearable solution, which leverages beat-to-beat accurate optical heart-rate technology. This enables continuous, 24/7 monitoring for arrhythmias, with a particular focus on atrial fibrillation, a primary risk factor for strokes. The device is engineered for user convenience, requiring no specialized patient training and allowing for extended wear without impacting daily activities. PulseOn's pioneering technology aims to enhance stroke prevention through earlier diagnosis of arrhythmias.
How much funding has PulseOn raised?
PulseOn has raised a total of $2.7M across 2 funding rounds:
Angel/Seed
$1.4M
Unspecified
$1.3M
Angel/Seed (2013): $1.4M, investors not publicly disclosed
Unspecified (2014): $1.3M, investors not publicly disclosed
What's next for PulseOn?
The recent major strategic investment signals a pivotal growth phase for PulseOn, likely enabling the company to scale its operations, expand market reach, and further develop its innovative arrhythmia detection technology. This enterprise-level funding suggests a strong investor confidence in PulseOn's potential to disrupt the medical diagnostics landscape and address critical healthcare needs related to cardiovascular health and stroke prevention.
See full PulseOn company page
